Correlation Between Elevation Oncology and Cidara Therapeutics

Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elevation Oncology and Cidara Therapeutics, you can compare the effects of market volatilities on Elevation Oncology and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Cidara Therapeutics.

Diversification Opportunities for Elevation Oncology and Cidara Therapeutics

0.0

Correlation Coefficient

Elevation Oncology  Cidara Therapeutics

Pay attention - limited upside

The 3 months correlation between Elevation and Cidara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Cidara Therapeutics go up and down completely randomly.

Pair Corralation between Elevation Oncology and Cidara Therapeutics

Given the investment horizon of 90 days Elevation Oncology is expected to under-perform the Cidara Therapeutics. In addition to that, Elevation Oncology is 1.83 times more volatile than Cidara Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Cidara Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest  2,525  in Cidara Therapeutics on December 30, 2024 and sell it today you would lose (286.00) from holding Cidara Therapeutics or give up 11.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Elevation Oncology  vs.  Cidara Therapeutics

Elevation Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Cidara Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cidara Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Cidara Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Elevation Oncology and Cidara Therapeutics

The main advantage of trading using opposite Elevation Oncology and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.

The idea behind Elevation Oncology and Cidara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.